Information profiles on potential occupational hazards: copper and compounds

Details

• Description:
  Information was provided concerning inorganic copper compounds, which have an annual production of at least 1 million pounds, and for organic copper compounds, with an annual production of at least 100,000 pounds. These compounds included copper (7440508) metal, copper-acetate (142712), copper arsenate (7778418), copper-carbonate (12069691), cuprous-chloride (7758896), cupric-chloride (7447394), copper-cyanide (544923), copper-2-ethylhexanoate (149111), copper- hydroxide (20427592), copper-8-hydroxyquinolate (10380286), copper- naphthenate (1338029), copper-nitrate (3251238), copper-oleate (1120441), cuprous-oxide (1317391), cupric-oxide (1317380), copper- sulfate (7758987), and copper-sulfide (1317404). Information provided included synonyms, chemical structure, physical and chemical properties, manufacturing processes and volumes, uses, manufacturers, distributors, and occupational exposures. Biological effects were reported as discovered through animal studies and included data on subchronic exposures, chronic exposure, carcinogenicity, mutagenicity, teratogenicity, reproductive effects, human pharmacokinetics, health effects on workers, target organ toxicity, ongoing studies and suggestions for further reading. [Description provided by NIOSH]
• Subjects:
  Carcinogens Epidemiology Hazardous Substances Laboratories Metals Metal Workers Mutagens Occupational Exposure Occupational Health Safety Teratogenesis

  More +
• Keywords:
  Contract-210-79-0030 Copper-compounds Laboratory-animals Metal-industry NIOSH-Contract Occupational-exposure Teratogens Toxic-effects
• Document Type:
  Text
• Funding:
  Contract
• Genre:
  Final Contract Report ; Final Contract Report
• Place as Subject:
  New York ; OSHA Region 2
• CIO:
  National Institute for Occupational Safety and Health (NIOSH) ; National Institute for Occupational Safety and Health (NIOSH)
• Topic:
  Workplace Safety & Health ; Workplace Safety & Health
• Location:
  North America ; North America
• Pages in Document:
  1-178
• NIOSHTIC Number:
  nn:00188263
• NTIS Accession Number:
  PB89-216212
• Citation:
  Center for Chemical Hazard Assessment, Syracuse Research Corporation, Syracuse, New York, SRC TR 81-626, Second Draft 1982 Mar; :1-178
• CAS Registry Number:
  Basic copper carbonate (CAS RN 12069-69-1) ; Bis(8-quinolinolato)copper (CAS RN 10380-28-6) ; Copper (CAS RN 7440-50-8) ; Copper arsenate (Cu3(AsO4)2) (CAS RN 7778-41-8) ; Copper hydroxide (CAS RN 20427-59-2) ; Copper oxide (Cu2O) (CAS RN 1317-39-1) ; Copper oxide (CuO) (CAS RN 1317-38-0) ; Copper sulfate (CAS RN 7758-98-7) ; Copper sulfide (CuS) (CAS RN 1317-40-4) ; Copper(II) 2-ethylhexanoate (CAS RN 149-11-1) ; Cupric acetate (CAS RN 142-71-2) ; Cupric chloride (CAS RN 7447-39-4) ; Cupric nitrate (CAS RN 3251-23-8) ; Cupric oleate (CAS RN 1120-44-1) ; Cuprous chloride (CAS RN 7758-89-6) ; Cuprous cyanide (CAS RN 544-92-3) ; Naphthenic acids, copper salts (CAS RN 1338-02-9) ; Basic copper carbonate (CAS RN 12069-69-1) ; Bis(8-quinolinolato)copper (CAS RN 10380-28-6) ; Copper (CAS RN 7440-50-8) ; Copper arsenate (Cu3(AsO4)2) (CAS RN 7778-41-8) ; Copper hydroxide (CAS RN 20427-59-2) ; Copper oxide (Cu2O) (CAS RN 1317-39-1) ; Copper oxide (CuO) (CAS RN 1317-38-0) ; Copper sulfate (CAS RN 7758-98-7) ; Copper sulfide (CuS) (CAS RN 1317-40-4) ; Copper(II) 2-ethylhexanoate (CAS RN 149-11-1) ; Cupric acetate (CAS RN 142-71-2) ; Cupric chloride (CAS RN 7447-39-4) ; Cupric nitrate (CAS RN 3251-23-8) ; Cupric oleate (CAS RN 1120-44-1) ; Cuprous chloride (CAS RN 7758-89-6) ; Cuprous cyanide (CAS RN 544-92-3) ; Naphthenic acids, copper salts (CAS RN 1338-02-9)
• Federal Fiscal Year:
  1982
• Peer Reviewed:
  False
• Source Full Name:
  Center for Chemical Hazard Assessment, Syracuse Research Corporation, Syracuse, New York, SRC TR 81-626, Second Draft
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:92a65f843c81db378048be22717a312af72221dfa1f3092a39ff67af72ee0963d5ef3ed91188469c40823f1a86dfc4e883403696a0f5abcfae5b29f818dde968
• Download URL:
  https://stacks.cdc.gov/view/cdc/204940/cdc_204940_DS1.pdf
• File Type:
  [PDF - 4.57 MB ]